Ask Pharm and Innovent Announce Strategic Collaboration for Limertinib, a Third-generation...
October 8,2024
SAN FRANCISCO, U.S., SUZHOU, China, Sept 30, 2024 —Jiangsu Aosaikang Pharmaceutical Co. Ltd. (ASK Pharm, 002755.SZ), and Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceu...
Detail>